Abstract
Microbial biofilms are mainly studied due to detrimental effects on human health but they are also well established in industrial biotechnology for the production of chemicals. Moreover, biofilm can be considered as a source of novel drugs since the conditions prevailing within biofilm can allow the production of specific metabolites. Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 when grown in biofilm condition produces an anti-biofilm molecule able to inhibit the biofilm of the opportunistic pathogen Staphylococcus epidermidis. In this paper we set up a P. haloplanktis TAC125 biofilm cultivation methodology in automatic bioreactor. The biofilm cultivation was designated to obtain two goals: (1) the scale up of cell-free supernatant production in an amount necessary for the anti-biofilm molecule/s purification; (2) the recovery of P. haloplanktis TAC125 cells grown in biofilm for physiological studies. We set up a fluidized-bed reactor fermentation in which floating polystyrene supports were homogeneously mixed, exposing an optimal air–liquid interface to let bacterium biofilm formation. The proposed methodology allowed a large-scale production of anti-biofilm molecule and paved the way to study differences between P. haloplanktis TAC125 cells grown in biofilm and in planktonic conditions. In particular, the modifications occurring in the lipopolysaccharide of cells grown in biofilm were investigated.
Similar content being viewed by others
References
Artini M, Papa R, Scoarughi GL, Galano E, Barbato G, Pucci P, Selan L (2013) Comparison of the action of different proteases on virulence properties related to the staphylococcal surface. J Appl Microbiol 114:266–277
Bowman JP, McCammon SA, Dann AL (2005) Biogeographic and quantitative analyses of abundant uncultivated gamma-proteobacterial clades from marine sediment. Microb Ecol 49:451–460
Carillo S, Casillo A, Pieretti G, Parrilli E, Sannino F, Bayer-Giraldi M, Cosconati S, Novellino E, Ewert M, Deming JW, Lanzetta R, Marino G, Parrilli M, Randazzo A, Tutino ML, Corsaro MM (2015) Unique capsular polysaccharide structure from the Psychrophilic Marine Bacterium Colwellia psychrerythraea 34H. J Am Chem Soc 137:179–189
Chalabaev S, Chauhan A, Novikov A, Iyer P, Szczesny M, Beloin C, Caroff M, Ghigo JM (2014) Biofilms formed by gram-negative bacteria undergo increased lipid a palmitoylation, enhancing in vivo survival. MBio 19(5):e01116–e01214
Cheng KC, Demirci A, Catchmark JM (2010) Advances in biofilm reactors for production of value-added products. Appl Microbiol Biotechnol 87:445–456
Ciornei CD, Novikov A, Beloin C, Fitting C, Caroff M, Ghigo JM, Cavaillon JM, Adib-Conquy M (2010) Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes. Innate Immun 16:288–301
Corsaro MM, Lanzetta R, Parrilli E, Parrilli M, Tutino ML (2001) Structural investigation on the lipooligosaccharide fraction of psychrophilic Pseudoalteromonas haloplanktis TAC 125 bacterium. Eur J Biochem 268:5092–5097
de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE (2013) Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 16:580–589
Fondi M, Maida I, Perrin E, Mellera A, Mocali S, Parrilli E, Tutino ML, Liò P, Fani R (2015) Genome-scale metabolic reconstruction and constraint-based modelling of the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Environ Microb 17:751–766
Galanos C, Lüderitz O, Westphal O (1969) New method for the extraction of R Lipopolysaccharides. Eur J Biochem 9:245–249
Giuliani M, Parrilli E, Ferrer P, Baumann K, Marino G, Tutino ML (2011) Process optimization for recombinant protein production in the psychrophilic bacterium Pseudoalteromonas haloplanktis. Process Biochem 46:953–959
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108
Hansen SK, Rainey PB, Haagensen JA, Molin S (2007) Evolution of species interactions in a biofilm community. Nature 445:533–536
Heilmann C, Gerke C, Perdreau-Remington F, Götz F (1996) Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun 64:277–282
Kiran GS, Sabarathnam B, Selvin J (2010) Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei. FEMS immunolo med microbial 59:432–438
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Medigue C, Krin E, Pascal G et al (2005) Coping with cold: the genome of the versatile marine Antarctica bacterium Pseudoalteromonas haloplanktis TAC125. Genome Res 15:1325–1335
Ni N, Li M, Wang J, Wang B (2009) Inhibitors and antagonists of bacterial quorum sensing. Med Res Rev 29:65–124
Papa R, Glagla S, Danchin A, Schweder T, Marino G, Duilio A (2006) Proteomic identification of a two-component regulatory system in Pseudoalteromonas haloplanktis TAC125. Extremophiles 10:483–491
Papa R, Artini M, Cellini A, Tilotta M, Galano E, Pucci P, Amoresano A, Selan L (2013a) A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus. Microb Pathog 63:44–53
Papa R, Parrilli E, Sannino F, Barbato G, Tutino ML, Artini M, Selan L (2013b) Anti-biofilm activity of the Antarctic marine bacterium Pseudoalteromonas haloplanktis TAC125. Res Microbiol 164(5):450–456
Papa R, Selan L, Parrilli E, Tilotta M, Sannino F, Feller G, Tutino ML, Artini M (2015) Anti-biofilm activities from marine cold adapted bacteria against staphylococci and Pseudomonas aeruginosa. Microbiol, Front. doi:10.3389/fmicb.2015.01333
Parrilli E, Papa R, Carillo S, Tilotta M, Casillo A, Sannino F, Cellini A, Artini M, Selan L, Corsaro MM, Tutino ML (2015) Anti-biofilm activity of Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm: evidence of a signal molecule involvement? Int J Immunopathol Pharmacol 28:104–113
Percival SL, Suleman L, Vuotto C, Donelli G (2015) Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol 64:323–334
Piette F, D’Amico S, Struvay C, Mazzucchelli G, Renaut J, Tutino ML, Danchin A, Leprince P, Feller G (2010) Proteomics of life at low temperatures: trigger factor is the primary chaperone in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Mol Microbiol 76:120–132
Piette F, D’Amico S, Mazzucchelli G, Danchin A, Leprince P, Feller G (2011) Life in the cold: a proteomic study of cold-repressed proteins in the antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Appl Environ Microbiol 77:3881–3883
Pongtharangku T, Demirci A (2007) Online recovery of nisin during fermentation and its effect on nisin production in biofilm reactor. Appl Microbiol Biotechnol 74:555–662
Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T (2009) Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology 155:2148–2156
Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635–700
Rosche B, Li XZ, Hauer B, Schmid A, Buehler K (2009) Microbial biofilms: a concept for industrial catalysis? Trends Biotechnol 27:636–643
Szilágyi N, Kovács R, Kenyeres I, Csikor Z (2013) Biofilm development in fixed bed biofilm reactors: experiments and simple models for engineering design purposes. Water Sci Technol 68:1391–1399
Tsai CM, Frasch CE (1982) Staining of lipopolysaccharide in SDS polyacrylamide gels using silver staining method. Anal Biochem 119:115–119
Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert P, Ghigo JM (2006) Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide. Proc Natl Acad Sci USA 3:12558–12563
Wilmes B, Hartung A, Lalk M, Liebeke M, Schweder T, Neubauer P (2010) Fed-batch process for the psychrotolerant marine bacterium Pseudoalteromonas haloplanktis. Microb Cell Fact 9:72
Acknowledgments
This work was supported by Programma Nazionale di Ricerche in Antartide 2013/B1.04 Tutino and Programma Operativo Nazionale Ricerca e Competitività 2007–2013 (D. D. Prot. n. 01/Ric. del 18.1.2010)-PON01_01802.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by H. Atomi.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Parrilli, E., Ricciardelli, A., Casillo, A. et al. Large-scale biofilm cultivation of Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 for physiologic studies and drug discovery. Extremophiles 20, 227–234 (2016). https://doi.org/10.1007/s00792-016-0813-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00792-016-0813-2